DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,184,253 | -21.2% | 2,364,314 | -1.0% | 0.00% | 0.0% |
| Q2 2023 | $26,873,337 | +61.2% | 2,388,741 | +65.1% | 0.00% | – |
| Q1 2023 | $16,666,641 | -12.6% | 1,446,757 | -12.0% | 0.00% | -100.0% |
| Q4 2022 | $19,058,713 | +12.1% | 1,644,410 | +22.9% | 0.00% | – |
| Q3 2022 | $16,997,000 | +87.3% | 1,338,365 | +1.3% | 0.00% | – |
| Q2 2022 | $9,077,000 | -32.4% | 1,321,225 | -5.2% | 0.00% | – |
| Q1 2022 | $13,437,000 | -18.8% | 1,393,941 | +0.1% | 0.00% | – |
| Q4 2021 | $16,558,000 | -21.2% | 1,392,722 | +7.7% | 0.00% | -100.0% |
| Q3 2021 | $21,003,000 | -17.8% | 1,293,342 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $25,561,000 | +88.3% | 1,214,883 | +39.0% | 0.00% | – |
| Q1 2021 | $13,573,000 | -6.4% | 873,973 | +26.6% | 0.00% | – |
| Q4 2020 | $14,502,000 | +1497.1% | 690,582 | +1434.6% | 0.00% | – |
| Q3 2020 | $908,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |